Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 1
1951 1
1953 1
1954 1
1955 2
1956 2
1957 1
1958 2
1959 2
1961 1
1962 11
1963 13
1964 16
1965 12
1966 12
1967 17
1968 19
1969 9
1970 27
1971 19
1972 17
1973 14
1974 17
1975 24
1976 19
1977 15
1978 18
1979 22
1980 24
1981 27
1982 31
1983 30
1984 44
1985 59
1986 47
1987 62
1988 66
1989 68
1990 88
1991 57
1992 66
1993 80
1994 88
1995 88
1996 101
1997 131
1998 107
1999 131
2000 128
2001 165
2002 144
2003 181
2004 198
2005 173
2006 180
2007 226
2008 179
2009 217
2010 244
2011 219
2012 218
2013 224
2014 214
2015 251
2016 218
2017 245
2018 292
2019 284
2020 341
2021 402
2022 363
2023 336
2024 343
2025 358
2026 138

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,421 results

Results by year

Filters applied: . Clear all
Page 1
Single-cell analysis reveals immune cell abnormalities underlying the clinical heterogeneity of patients with systemic sclerosis.
Shimagami H, Nishimura K, Matsushita H, Metsugi S, Kato Y, Kawasaki T, Tsujimoto K, Edahiro R, Itotagawa E, Naito M, Kawada S, Nakatsubo D, Matsukawa K, Namba-Hamano T, Inoue K, Takahashi A, Mizui M, Kato S, Hikita H, Nakazawa S, Kakuta Y, Konaka H, Mitsumoto K, Ishikawa N, Fujimoto J, Higa S, Omiya R, Isaka Y, Takehara T, Nonomura N, Okada Y, Hattori K, Narazaki M, Kumanogoh A, Nishide M. Shimagami H, et al. Among authors: kato s. Nat Commun. 2025 Jun 17;16(1):4949. doi: 10.1038/s41467-025-60034-7. Nat Commun. 2025. PMID: 40527894 Free PMC article.
FSP1-mediated lipid droplet quality control prevents neutral lipid peroxidation and ferroptosis.
Lange M, Wölk M, Doubravsky CE, Hendricks JM, Kato S, Otoki Y, Styler B, Nakagawa K, Fedorova M, Olzmann JA. Lange M, et al. Among authors: kato s. bioRxiv [Preprint]. 2025 Jan 6:2025.01.06.631537. doi: 10.1101/2025.01.06.631537. bioRxiv. 2025. Update in: Nat Cell Biol. 2025 Nov;27(11):1902-1913. doi: 10.1038/s41556-025-01790-y. PMID: 39829838 Free PMC article. Updated. Preprint.
Association of Epstein-Barr virus genomic alterations with human pathologies.
Khine HT, Sato Y, Hamada M, Umeda M, Iizuka A, Son S, Arai H, Kojima Y, Watanabe T, Naruse A, Goto K, Ohshima K, Akutsu Y, Nakaguro M, Satou A, Kataoka H, Ito Y, Sawada A, Kato S, Kawada JI, Murata T, Okuno Y, Kimura H. Khine HT, et al. Among authors: kato s. Blood. 2025 Sep 25;146(13):1533-1545. doi: 10.1182/blood.2024028055. Blood. 2025. PMID: 40569273 Free PMC article.
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial.
Gooderham MJ, Alonso-Llamazares J, Bagel J, Bhatia N, Bukhalo M, DuBois J, Ferris LK, Green L, Kircik LH, Lockshin B, Loo WJ, Papp KA, Soung J, Seal MS, Snyder S, Kato S, Krupa D, Burnett P, Berk DR, Chu DH. Gooderham MJ, et al. Among authors: kato s. JAMA Dermatol. 2025 Jul 1;161(7):698-706. doi: 10.1001/jamadermatol.2025.1136. JAMA Dermatol. 2025. PMID: 40332898 Free PMC article. Clinical Trial.
Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations.
Weitz J, Nishizaki D, Liau J, Patel J, Ng I, Sun S, Ramms D, Zou J, Wishart B, Rull J, Baumgartner J, Kelly K, White R, Veerapong J, Hosseini M, Patel H, Botta G, Gutkind JS, Tiriac H, Kato S, Lowy AM. Weitz J, et al. Among authors: kato s. J Clin Oncol. 2025 Feb 20;43(6):705-715. doi: 10.1200/JCO.24.00511. Epub 2024 Oct 16. J Clin Oncol. 2025. PMID: 39413348 Free PMC article.
Cancer treatment paradigms in the precision medicine era.
Subbiah V, Curigliano G, Sicklick JK, Kato S, Tasken K, Medford A, Rieke DT, Chen HZ, Wahida A, Buschhorn L, Horgan D, Kurzrock R. Subbiah V, et al. Among authors: kato s. Nat Med. 2025 Nov;31(11):3609-3611. doi: 10.1038/s41591-025-03711-w. Nat Med. 2025. PMID: 40394190 No abstract available.
OMG! A proteomic determinant of neurodegenerative resiliency.
Duggan MR, Oh HS, Frank P, Gomez GT, Zweibaum D, Cui Y, Chen J, Surapaneni A, Blew CO, Dark HE, Joynes CM, Kandala S, Bilgel M, Farinas A, Erus G, Tian Q, Candia J, Pucha KA, Landman BA, Dumitrescu L, Hohman TJ, Lewis A, Moghekar A, Siavoshi F, Ali M, Liu M, Xu Y, Western D, Kaneko N, Kato S, Furuichi M, Shibayama M, Katsuno M, Nishita Y, Otsuka R, Gottesman RF, Dammer EB, Seyfried NT, Levey AI, B Johnson EC, Mormino E, Wagner AD, Poston KL, Kapogiannis D, Grams ME, Bhargava P, Waga I, Davatzikos C, Resnick SM, Ferrucci L, Bennett DA, Cruchaga C, Wyss-Coray T, Kivimäki M, Coresh J, Walker KA. Duggan MR, et al. Among authors: kato s. Mol Neurodegener. 2026 Jan 5;21(1):9. doi: 10.1186/s13024-025-00921-1. Mol Neurodegener. 2026. PMID: 41491993 Free PMC article.
7,421 results